EastHORN Clinical Services
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
EastHORN Clinical Services - overview
Established
2004
Location
Warsaw, -, Poland
Primary Industry
Healthcare
About
Based in Warsaw, Poland, and founded in 2004 by Malgorzata Szerszeniewska (CEO), and Alan Wood, EastHORN Clinical Services operates as a research company that provides clinical services on CRO (Contract Research Organization). In November 2022, Novotech (Australia) Pty Limited, a portfolio company of TPG, GIC, Kaiser Permanente, and Sequoia Capital, acquired EastHORN Clinical Services. EastHORN has been involved in studies that include from Phase I to Phase IV in therapeutic areas, including oncology, cardiology, ophthalmology, neurology and psychiatry, infectious diseases, gastroenterology, urology and nephrology, dermatology, immunology, metabolic disorders, pediatrics, medical devices, and other rare diseases.
Current Investors
Novotech
Primary Industry
Healthcare
Sub Industries
Clinics/Outpatient Services
Website
www.easthorn.eu
Verticals
HealthTech
Company Stage
Add-on
Total Amount Raised
Subscriber access only
EastHORN Clinical Services - financials
| Fiscal Year Ended | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|
| Revenue (USD) | 4,729,861.2 | 4,714,794.4 | 4,480,903.1 | 4,640,766.6 | - | - | - |
| % Revenue Growth (YoY) | - | (0.3%) | (5.0%) | 3.6% | - | - | - |
| EBITDA (USD) | 222,136 | 203,284.9 | 174,503.2 | 348,603.9 | - | - | - |
| Operating Income (USD) | 159,019.9 | 175,536.9 | 168,968.4 | 313,530.5 | - | - | - |
| Operating Margin | 3.4% | 3.7% | 3.8% | 6.8% | - | - | - |
| % EBITDA Margin | 4.7% | 4.3% | 3.9% | 7.5% | - | - | - |
| NET Income (USD) | 124,052.4 | 137,865.3 | 150,381.3 | 281,021.1 | - | - | - |
| % Net Margin | 2.6% | 2.9% | 3.4% | 6.1% | - | - | - |
EastHORN Clinical Services - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | EastHORN Clinical Services | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.